Identification of target and pathway of aspirin combined with Lipitor treatment in prostate cancer through integrated bioinformatics analysis

CONCLUSION: The enrichment pathways and targets of Lipitor combined with aspirin in PCa are discovered, and DSCC1 silencing can potentiate the effect of Lipitor combined with aspirin in the treatment of PCa.PMID:35926565 | DOI:10.1016/j.taap.2022.116169

Source: Toxicology and Applied Pharmacology - August 4, 2022 Category: Toxicology Authors: Xiao Wang Yi Wu Junlei Liu Xuetao Xu Zhaojun Sheng Wenfeng Liu Min Chen Yanyan Ma Denggao Zhao Dongli Li Xi Zheng Source Type: research